Global Dermatophytic Onychomycosis Market - Size, Analysis, Share, Trends to 2021

Submitted by: Submitted by

Views: 10

Words: 4899

Pages: 20

Category: Business and Industry

Date Submitted: 02/01/2016 03:20 AM

Report This Essay

Global Dermatophytic Onychomycosis Market - Asia Pacific is

projected to expand at the highest CAGR by 2015 - 2021

Persistence Market Research

Global Dermatophytic Onychomycosis

Market expected to progress US$ 4,706.3 Mn

by the end of 2021 - Persistence Market

Research

Persistence Market Research

1

Global Dermatophytic Onychomycosis Market - Asia Pacific is

projected to expand at the highest CAGR by 2015 - 2021

Persistence Market Research Released New Market Report “Global Market Study on

Dermatophytic Onychomycosis Therapeutics (DOT): North America Expected to

Account for Maximum Market Share by 2021”.

The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a

healthy CAGR during the forecast period. By product type, the market is segmented into Nail

paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC)

sub segments. The nail paint segment is expected to contribute a maximum share to the

global dermatophytic onychomycosis therapeutics market and expand at the fastest CAGR

of 8.3% during the forecast period. By treatment, the market is segmented into topical and

oral therapy. Among these, the topical segment is anticipated to be dominant throughout the

forecast period and projected to account for about 70% share of the total global

dermatophytic onychomycosis market revenue by 2021. By distribution channels, the

market is segmented into hospitals, dermatology and podiatry clinics, independent

pharmacies, mail order pharmacies, and drug stores. Among these, drug stores are

estimated to be largest segment with 47% share of the total global market revenue by 2015

end. The drug stores segment is expected to register the fastest CAGR during the forecast

period. Independent pharmacies are projected to be the second most attractive segment of

the global dermatophytic onychomycosis therapeutics market by 2015 end.

Market growth is primarily driven by factors such as increase in the prevalence...